Nursing News and Research

Latest Nursing News and Research

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Survival rates of wealthier patients with glioblastoma are longer than poorer patients

Survival rates of wealthier patients with glioblastoma are longer than poorer patients

Hartford Faculty Scholars Program grants two-year award to geriatric social work researchers

Hartford Faculty Scholars Program grants two-year award to geriatric social work researchers

Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma

Roche, Bristol-Myers Squibb to evaluate YERVOY and vemurafenib treatment for metastatic melanoma

Many women over 70 with stage I breast cancer opt for radiation therapy: ASCO

Many women over 70 with stage I breast cancer opt for radiation therapy: ASCO

AHRQ: States see improvements in health care quality, but disparities persist

AHRQ: States see improvements in health care quality, but disparities persist

Decision Resources, Wolters Kluwer Health & Pharma create TPA process for mutual customers

Decision Resources, Wolters Kluwer Health & Pharma create TPA process for mutual customers

APC8015F investigational vaccine improves survival of prostate cancer patients

APC8015F investigational vaccine improves survival of prostate cancer patients

Transitional care can improve health outcomes and reduce hospital readmissions

Transitional care can improve health outcomes and reduce hospital readmissions

Study finds strong link between head injury and violent behavior in young people

Study finds strong link between head injury and violent behavior in young people

PQA honors Kaiser Permanente for outstanding performance in medication safety

PQA honors Kaiser Permanente for outstanding performance in medication safety

Loyola to offer free lecture on anterior-approach hip replacement surgery

Loyola to offer free lecture on anterior-approach hip replacement surgery

SHEA, ASGE update Flexible gastrointestinal endoscope guideline

SHEA, ASGE update Flexible gastrointestinal endoscope guideline

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

Study explains differences between male and female victims in community violence assaults

Study explains differences between male and female victims in community violence assaults

Lymphocyte count serves as simple and effective prognostic indicator in renal cell carcinoma

Lymphocyte count serves as simple and effective prognostic indicator in renal cell carcinoma

ECPI College of Technology announces name change to ECPI University

ECPI College of Technology announces name change to ECPI University

State roundup: Colo. Gov. Vetoes cost sharing bill for children's health plan

State roundup: Colo. Gov. Vetoes cost sharing bill for children's health plan

Viewpoints: More on Medicare's 'hard choices'; elderly and anti-psychotics; Calif. insurance rate hikes

Viewpoints: More on Medicare's 'hard choices'; elderly and anti-psychotics; Calif. insurance rate hikes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.